Erste Asset Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-30,700
| Closed | -$147K | – | 681 |
|
|
2023
Q2 | $147K | Hold |
30,700
| – | – | ﹤0.01% | 505 |
|
|
2023
Q1 | $163K | Hold |
30,700
| – | – | ﹤0.01% | 505 |
|
|
2022
Q4 | $307K | Hold |
30,700
| – | – | 0.01% | 457 |
|
|
2022
Q3 | $686K | Hold |
30,700
| – | – | 0.02% | 386 |
|
|
2022
Q2 | $764K | Buy |
30,700
+10,000
| +48% | +$249K | 0.02% | 388 |
|
|
2022
Q1 | $825K | Buy |
20,700
+9,500
| +85% | +$379K | 0.02% | 378 |
|
|
2021
Q4 | $663K | Sell |
11,200
-6,000
| -35% | -$355K | 0.01% | 403 |
|
|
2021
Q3 | $1.03M | Hold |
17,200
| – | – | 0.02% | 337 |
|
|
2021
Q2 | $1.53M | Hold |
17,200
| – | – | 0.03% | 313 |
|
|
2021
Q1 | $1.27M | Sell |
17,200
-5,500
| -24% | -$407K | 0.03% | 318 |
|
|
2020
Q4 | $2.1M | Buy |
+22,700
| New | +$2.1M | 0.06% | 259 |
|